nashville iv therapy
Abdulghani AA, Sherr S, Shirin S, Solodkina G, Tapia EM, Wolf B, Gottlieb AB
Originally developed by Metabolic Pharmaceuticals in Australia, it was designed as a shorter, modified version of hGH to retain its fat-burning (lipolytic) properties
Once weight loss stabilizes, the next question is often what to do about skin laxity, uneven fullness, or body shape changes that medication alone will not address
Areas of active exploration include: Gastrointestinal healing (e.g., IBD, ulcers, leaky gut) Neurodegenerative conditions (e.g., Parkinsons, Alzheimers) Vascular repair (e.g., post-stroke recovery) PTSD and mood disorders Spinal cord injury repair With its unique ability to bridge multiple systemsfrom vascular to neural to connective tissueBPC-157 holds promise in areas far beyond orthopedic healing
IV (weekly): 250 mg/week or 500 mg/week , depending on the infusion length/volume